Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹2,413 Cr₹2,152 Cr₹1,813 Cr₹920 Cr₹1,137 Cr

What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Operating Activities ratio of MANKIND PHARMA is ₹2,413 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹2,413 Cr
Mar2024₹2,152 Cr
Mar2023₹1,813 Cr
Mar2022₹920 Cr
Mar2021₹1,137 Cr

How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹2,413 Cr
12.12
Mar2024 ₹2,152 Cr
18.70
Mar2023 ₹1,813 Cr
97.15
Mar2022 ₹920 Cr
-19.12
Mar2021 ₹1,137 Cr -

Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹104,478.7 Cr 7% 2% 7.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,148.0 Cr 2.6% 1.2% 13% Stock Analytics
DIVIS LABORATORIES ₹179,009.0 Cr 1.3% -2.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,779.0 Cr 1.5% 0.7% 37.1% Stock Analytics
CIPLA ₹115,772.0 Cr 6.1% 2.4% -5.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,616.0 Cr 2.6% -0.4% -2.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

7%

2%

7.9%

SENSEX

-0.8%

1.4%

-6.8%


You may also like the below Video Courses